Enzo Biochem, Inc. (ENZ) Reports Q2 Loss of $0.04
Tweet Send to a FriendGet Alerts ENZ Hot Sheet
Price: $2.25 -1.75%
EPS Growth %: -250.0%
Financial Fact:
Total operating expenses: 28.2M
Today's EPS Names:
NED, OESX, WSTL, More
EPS Growth %: -250.0%
Financial Fact:
Total operating expenses: 28.2M
Today's EPS Names:
NED, OESX, WSTL, More
Trade ENZ Now!
Enzo Biochem, Inc. (NYSE: ENZ) reported Q2 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $25 million, versus $23.7 million reported last year.
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Heico Corp. (HEI) Tops Q1 EPS by 4c, Boosts Forecast
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
